Shyoko Honiden MD, MSc
Associate Professor of Medicine; Director of Simulation for Internal Medicine; Director, Medical Intensive Care Unit, Internal Medicine, Yale School of Medicine, New Haven, ConnecticutDr. Shyoko Honiden is a pulmonologist and critical care specialist practicing in New Haven, Connecticut. She is currently the director of the Medical Intensive Care Unit at Yale New Haven Hospital, and, prior to taking on this position, served as Program Director for the Pulmonary and Critical Care Medicine fellowship program at the Yale School of Medicine. Her clinical focus is on the delivery of complex care in the ICU, particularly in the care of patients with ARDs, sepsis, and acute liver failure. Her clinical and research interests also include metabolic issues pertaining to hyperglycemia and nutritional support during critical illness.
Dr. Honiden has served in a variety of leadership roles in the realm of medical education. In addition to her experience as fellowship Program Director, she serves as the Director for the Medical ICU Electives program for students and residents and is involved in simulation and experiential curriculum development. She is an active participant in ICU-related quality-improvement projects as well. She has a deep interest in quality and safety, ensuring best practices are adhered to in the ICU.
Dr. Honiden is a member of the Society of Critical Care Medicine, American Thoracic Society, American College of Chest Physicians, and the American Board of Internal Medicine. She is board-certified in internal medicine, pulmonary medicine, and critical care medicine.
Recent Contributions to PracticeUpdate:
- COVID-19 Hospital Admissions and Deaths After Vaccinations in the Scotland Population
- Errors of Commission in Cardiac Arrest Care in the Intensive Care Unit
- Impact of Blood Product Transfusions on the Risk of ICU-Acquired Infections in Septic Shock
- Update on COPD in 2020
- High-Dimensional Characterization of Post-Acute Sequalae of COVID-19
- 2020 Top Stories in Respiratory Medicine: The DEXA-ARDS Trial
- Covid-19 — Navigating the Uncharted
- Pharmacologic Treatments for COVID-19
- Interim Guidance for Basic and Advanced Life Support in Suspected or Confirmed COVID-19
- First Known Person-to-Person Transmission of COVID-19 in the United States